Literature DB >> 25080588

Multiple factors contribute to the peripheral induction of cerebral β-amyloidosis.

Yvonne S Eisele1, Sarah K Fritschi2, Tsuyoshi Hamaguchi3, Ulrike Obermüller4, Petra Füger4, Angelos Skodras4, Claudia Schäfer4, Jörg Odenthal4, Mathias Heikenwalder5, Matthias Staufenbiel4, Mathias Jucker1.   

Abstract

Deposition of aggregated amyloid-β (Aβ) peptide in brain is an early event and hallmark pathology of Alzheimer's disease and cerebral Aβ angiopathy. Experimental evidence supports the concept that Aβ multimers can act as seeds and structurally corrupt other Aβ peptides by a self-propagating mechanism. Here we compare the induction of cerebral β-amyloidosis by intraperitoneal applications of Aβ-containing brain extracts in three Aβ-precursor protein (APP) transgenic mouse lines that differ in levels of transgene expression in brain and periphery (APP23 mice, APP23 mice lacking murine APP, and R1.40 mice). Results revealed that beta-amyloidosis induction, which could be blocked with an anti-Aβ antibody, was dependent on the amount of inoculated brain extract and on the level of APP/Aβ expression in the brain but not in the periphery. The induced Aβ deposits in brain occurred in a characteristic pattern consistent with the entry of Aβ seeds at multiple brain locations. Intraperitoneally injected Aβ could be detected in blood monocytes and some peripheral tissues (liver, spleen) up to 30 d after the injection but escaped histological and biochemical detection thereafter. These results suggest that intraperitoneally inoculated Aβ seeds are transported from the periphery to the brain in which corruptive templating of host Aβ occurs at multiple sites, most efficiently in regions with high availability of soluble Aβ.
Copyright © 2014 the authors 0270-6474/14/3410264-10$15.00/0.

Entities:  

Keywords:  Abeta; cerebral beta-amyloidosis; peripheral induction; seeding

Mesh:

Substances:

Year:  2014        PMID: 25080588      PMCID: PMC6608275          DOI: 10.1523/JNEUROSCI.1608-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

Review 1.  β-Amyloid Prions and the Pathobiology of Alzheimer's Disease.

Authors:  Joel C Watts; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 2.  Neurodegenerative diseases: expanding the prion concept.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Annu Rev Neurosci       Date:  2015-03-30       Impact factor: 12.449

3.  Is Alzheimer's Disease Transmissible in Humans?

Authors:  Xian-Le Bu; Wei-Wei Li; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2019-04-29       Impact factor: 5.203

Review 4.  The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.

Authors:  Lary C Walker; Juliane Schelle; Mathias Jucker
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

Review 5.  APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

Authors:  Alex E Roher; Tyler A Kokjohn; Steven G Clarke; Michael R Sierks; Chera L Maarouf; Geidy E Serrano; Marwan S Sabbagh; Thomas G Beach
Journal:  Neurochem Int       Date:  2017-08-12       Impact factor: 3.921

6.  Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis.

Authors:  Lan Ye; Jay Rasmussen; Stephan A Kaeser; Anne-Marie Marzesco; Ulrike Obermüller; Jasmin Mahler; Juliane Schelle; Jörg Odenthal; Christian Krüger; Sarah K Fritschi; Lary C Walker; Matthias Staufenbiel; Frank Baumann; Mathias Jucker
Journal:  EMBO Rep       Date:  2017-07-12       Impact factor: 8.807

7.  Persistence of Aβ seeds in APP null mouse brain.

Authors:  Lan Ye; Sarah K Fritschi; Juliane Schelle; Ulrike Obermüller; Karoline Degenhardt; Stephan A Kaeser; Yvonne S Eisele; Lary C Walker; Frank Baumann; Matthias Staufenbiel; Mathias Jucker
Journal:  Nat Neurosci       Date:  2015-09-09       Impact factor: 24.884

8.  Transport of cargo from periphery to brain by circulating monocytes.

Authors:  Amarallys F Cintron; Nirjari V Dalal; Jeromy Dooyema; Ranjita Betarbet; Lary C Walker
Journal:  Brain Res       Date:  2015-07-10       Impact factor: 3.252

Review 9.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

Review 10.  Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nat Neurosci       Date:  2018-09-26       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.